Pacira Pharmaceuticals buy Raymond James
Start price
31.07.24
/
50%
€19.10
Target price
31.07.25
€34.20
Performance (%)
-20.94%
Price
03.10.24
€14.10
Summary
This prediction is currently active. The price of Pacira Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.94%. This prediction currently runs until 31.07.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 9.302% | 9.302% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Raymond_James for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Raymond James from $41.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Raymond_James for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€29.60
20.12.23
20.12.23
€38.31
20.12.24
20.12.24
-48.99%
03.10.24
03.10.24